AstraZeneca Appoints Pascal Soriot CEO

News   Aug 28, 2012

 
AstraZeneca Appoints Pascal Soriot CEO
 
 
 

RELATED ARTICLES

CMC Biologics Announces Development and Manufacturing Agreement with Harpoon Therapeutics

News

Companies have entered into agreement for the development and manufacturing of three TriTAC molecules for the treatment of cancers.

READ MORE

Serialization Capabilities Now Operational at Lonza Edinburgh Facility for Liquid-Filled Hard Capsules

News

Investment in former Capsugel site improves anti-counterfeiting security for Lonza’s global supply chain.

READ MORE

BioGenes Establishes Scientific Advisory Board

News

BioGenes GmbH, specializing in ELISA development and production and a global leader in host cell protein (HCP) assay development, announces the establishment of a Scientific Advisory Board.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE